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1 CF = cystic fibrosis; IDA = inner dynein arm; NO = nitric oxide; PCD = primary ciliary dyskinesia
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Introduction
The American Thoracic Society Meeting was held this
year in San Francisco, California. This meeting is the
largest scientific meeting in the world targeted to diseases
of the lung, with several thousand delegates in attendance
in 2001. Clinicians, scientists, and clinician-scientists
attended the meeting, together with a range of personnel
from allied fields. Though the main emphasis of the
meeting is on the common lung diseases, generally, each
year relatively rare diseases get some special attention.
This year, on consecutive days there were two sessions
on primary ciliary dyskinesia (PCD), a genetic disease of
ciliary structure and function. The sessions were well
attended by delegates from a range of disciplines, and the
speakers were selected from across the research spec-
trum. The aims of the presentations were to provide
updates on the nature of the disease and its use as a
human disease model, and also to report exciting new
findings in relation to clinical aspects, cell biology and
genetics.
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Abstract
Primary ciliary dyskinesia (PCD) is a genetic disorder of abnormal ciliary structure and function that
leads to defective mucociliary clearance, resulting in oto-sino-pulmonary disease, and infertility. The
disease is currently under intense investigation by a number of research groups worldwide. At the recent
American Thoracic Society meeting in San Francisco in May 2001, two sessions focused on PCD; a
symposium session on May 21 with several featured expert speakers was followed by a mini-symposium
on Tuesday May 22, with one featured speaker and presentation of nine abstracts covering a range of
research topics. Mattias Salathe (University of Miami, USA) and Stephen Brody (Washington University,
St Louis, USA) chaired the symposium session. Presentations focused on the clinical spectrum of PCD,
the genetics of PCD, a proteomics approach to detail the structure of cilia, the role of cilia in the
embryology of situs laterality, and airway epithelial cell biology. The mini-symposium was chaired by
Peadar Noone (University of North Carolina, USA) and Malcolm King (University of Alberta, USA) and
included presentations on the use of PCD as a human disease model, accurate definition of the
phenotype using clinical and cell biologic markers, and molecular studies. The latter reports ranged from
isolation of a protein involved in ciliary structure and function to genetic studies using linkage analysis
and the candidate gene approach. Clinicians and scientists alike displayed considerable interest at both
sessions, and there were several lively question–answer sessions.
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Clinical phenotype
The aspects of the clinical features of PCD were reviewed
by two featured speakers, Peter Cole (Host Defence Unit,
Brompton Hospital London, UK) and Peadar Noone (Uni-
versity of North Carolina at Chapel Hill, USA). Aruna
Sannuti (University of North Carolina at Chapel Hill, USA)
also presented clinical and phenotypic data from a
prospective study of a large cohort of patients with PCD.
The high proportion of patients with a history of neonatal
respiratory distress, recurrent otitis media, and a require-
ment for ear drainage tubes was again emphasized. The
importance of a careful diagnostic work-up and accurate
phenotyping for subsequent genetic studies was stressed.
Of particular note was the report of isolation of mucoid
Pseudomonas aeruginosa in older patients (9 out of 54)
with PCD. This is usually regarded as a strong marker of
cystic fibrosis (CF), a similar but distinct airway host
defence disease. Normal ion transport in nasal epithelia in
a subset of patients, the presence of situs inversus in 50%
of patients, and very low levels of nasal nitric oxide (NO) in
all PCD patients (see below) appeared to rule out coexis-
tent CF. This observation may yield insights into the patho-
genesis of Pseudomonas infection in patients with chronic
failure of the mucociliary apparatus other than CF.
Cell biologic aspects of PCD
In the symposium session, Dr Stripp (University of
Rochester, USA), Dr Sisson (University of Nebrasaka,
USA) and Dr Forteza (University of Miami, USA) all pre-
sented overviews of the complexity of airway epithelia,
ciliary development, signaling systems, and cilia in host
defence.
In the context of accurate diagnosis and phenotyping Dr
Sannuti (University of North Carolina at Chapel Hill, USA)
and Dr Estelle Escudier (Inserm 492, Creteil, France) pre-
sented data on a novel method using computer technol-
ogy imaging to accurately categorize ciliary dynein arm
defects in subgroups of patients with PCD. Dr Sannuti
showed that defects of the outer dynein arm are more
specific for PCD than defects in the inner dynein arm
(IDA), such that the IDA may be vulnerable to the effects
of non-specific (non-PCD) chronic inflammation. Dr
Escudier showed that although the IDA may be difficult to
characterize, a method using computer rotation of ciliary
electron microscopic images may be useful to diagnose a
proportion of patients as having genetically determined
defects in the IDA. Both computer-aided analyses pre-
sented by Drs Sannuti and Escudier of EM images
appeared to be reproducible and useful for phenotyping
patients with PCD, particularly in cohorting PCD patients
for genetic studies.
Low nasal NO levels have been observed to be a strong
feature of PCD, and Teresa Wodehouse (Brompton
Hospital, London, UK) and Michael Larj (University of
North Carolina at Chapel Hill, USA) presented data to
confirm this observation. Both speakers showed large
(n>50) datasets of patients with PCD exhibiting very low
exhaled levels of NO in nasal air, quite different to normals
and disease controls. The cause of the low levels of NO is
presently unknown, but speculation ranged from defective
expression of the nitric oxide synthase enzyme, iNOS, to a
primary defect related to the genetic mutation causing
PCD. Dr Larj showed that parents of patients with PCD
(presumably obligate carriers) without any clinical disease
can have intermediate levels of nasal NO. Finally, Karin
Storm Vans Gravesende (Boston University, USA)
showed a relationship between sequence variants in the
genes encoding for two of the three NO synthase iso-
forms (NOSII and NOSIII) and the diagnosis of PCD in a
group of well-characterized patients with the disease. The
observation of low levels of NO in PCD thus remains
unknown, but continued study of this phenomenon may
shed light on the source and role of NO in the upper
airway, particularly as related to host defence.
Proteomic and genetic approaches in PCD
Ciliary structure is very complex, but one approach to iso-
lating the abnormalities in PCD is proteomics. Larry
Ostrowski and Yan Zhang (both from University of North
Carolina, USA) presented data on the isolation and identi-
fication of proteins from the culture of cells from a patient
with PCD and missing IDA who had undergone transplan-
tation. Using protein gel electrophoresis, a protein band
was identified as missing from an axonemal isolate of the
patient’s airway epithelial cells. The protein was identified
as DNAH7, an axonemal dynein heavy chain. Although a
specific mutation in DNAH7 was not identified in the
patient, this protein is thought to be important for anchor-
ing or assembly of the axonemal heavy chain dynein in the
IDA in normal human cilia.
Several genetic studies were presented showing that the
use of candidate genes is a useful approach to identify the
mutations that cause PCD. Hannah Mitchison (University
of London, UK) presented an overview of genetic
approaches, while Gaelle Pennarun (Institut National de la
Sante, Paris, France), Maimoona Zariawala (University of
North Carolina at Chapel Hill, USA) and Michal Witt (The
Institute of Genetics, Poland) showed data from ongoing
genetic studies in PCD. Pennarun and co-workers
reported the first mutations in the DNAI1 gene in 1999
using the candidate gene approach, and at the meeting
she reported the further efforts of the group in testing can-
didate genes from two nonhuman models, Chlamy-
domonas (HP28) and a mouse model (hfh4). Dr Zariawala
showed mutations in DNAI1 in a well characterized group
of patients with PCD and outer dynein arm defects in two
unrelated families. These mutations included the previ-
ously reported splice mutation on one allele, and novelc
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mutations (a missense mutation, W568S and a nonsense
mutation, W568X) on the opposite allele. Finally, Dr Witt
showed that the linkage analysis in a large group of
patients with PCD may be useful, especially if the pheno-
type is strong. Patients with situs inversus and PCD
yielded especially high lod scores (>4) in a region of
chromosome 15q, while the total PCD patient group (with
and without situs inversus) yielded a lower mean lod score
Conclusion
The sessions illustrated the general interest in PCD, with
an international attendance from many countries. Although
PCD is relatively rare, it is likely to be under-recognized,
and further definition of the phenotype at a clinical and cell
biologic level, as described at the meeting, is likely to
increase our ability to recognize true genetic-linked abnor-
malities in ciliary structure and function causing PCD in
humans. Studies of the role of NO in PCD are likely to
increase our understanding of the role of NO in the airway,
and its relationship to ciliary structure and function.
Genetic studies will allow more precise definition of the
molecular abnormalities leading to PCD, increase our
understanding of ciliary structure and function, and allow
further development of methods to modulate cilia in vivo
using novel treatments.
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